4.7 Article

Automation-assisted versus manual reading of cervical cytology (MAVARIC): a randomised controlled trial

Journal

LANCET ONCOLOGY
Volume 12, Issue 1, Pages 56-64

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(10)70264-3

Keywords

-

Categories

Funding

  1. National Institute for Health Research Health Technology Assessment [03/04/02]
  2. Abbott Diagnostics
  3. Qiagen
  4. NIHR Manchester Biomedical Research Centre
  5. National Institute for Health Research [NF-SI-0509-10206, 03/04/02] Funding Source: researchfish

Ask authors/readers for more resources

Background The standard for reading cervical cytology is for a cytoscreener to manually search across an entire slide for abnormal cells using a conventional microscope. Automated technology can select fields of view to assess abnormal cells, which allows targeted reading by cytoscreeners. In the Manual Assessment Versus Automated Reading In Cytology (MAVARIC) trial, we compared the accuracy of these techniques for the detection of underlying disease. Methods For this randomised controlled trial, women aged 25-64 years undergoing primary cervical screening in Manchester, UK, were randomly assigned (1:2) to receive either manual reading only or paired reading (automation. assisted reading and manual reading), between March 1, 2006, and Feb 28, 2009. In the paired arm, two automated systems were used the ThinPrep Imaging System and the FocalPoint GS Imaging System. General practices and community clinics were randomised to either ThinPrep or to SurePath (for the FocalPoint system) liquid-based cytology with block randomisation stratified by deprivation index. Samples were then individually randomised to manual reading only or paired reading only. Laboratory staff were unaware of the allocation of each slide and concealment was maintained until the end of the reporting process. The primary outcome was sensitivity of automation-assisted reading relative to manual reading for the detection of underlying cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in the paired arm. This trial is registered, number ISRCTN66377374. Findings 73 266 liquid-based cytology samples were obtained from women undergoing primary cervical screening; 24 688 allocated to the manual-only arm and 48 578 to the paired-reading arm. Automation-assisted reading was 8% less sensitive than manual reading (relative sensitivity 0.92, 95% CI 0.89-0.95), which was equivalent to an absolute reduction in sensitivity of 6.3%, assuming the sensitivity of manual reading to be 79%. Specificity of automation-assisted reading relative to manual reading increased by 0.6% (1.006, 95% CI 1.005-1.007). Interpretation The inferior sensitivity of automation-assisted reading for the detection of CIN2+, combined with an inconsequential increase in specificity, suggests that automation-assisted reading cannot be recommended for primary cervical screening.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Obstetrics & Gynecology

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes

R. Manchanda, M. Burnell, F. Gaba, R. Desai, J. Wardle, S. Gessler, L. Side, S. Sanderson, K. Loggenberg, A. F. Brady, H. Dorkins, Y. Wallis, C. Chapman, C. Jacobs, R. Legood, U. Beller, I Tomlinson, U. Menon, I Jacobs

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)

Article Obstetrics & Gynecology

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study

F. Gaba, O. Blyuss, D. Chandrasekaran, M. Osman, S. Goyal, C. Gan, L. Izatt, V Tripathi, I Esteban, L. McNicol, K. Ragupathy, R. Crawford, D. G. Evans, R. Legood, U. Menon, R. Manchanda

Summary: The study found high acceptability of risk-reducing early salpingectomy and delayed oophorectomy (RRESDO) among premenopausal women at increased ovarian cancer risk, particularly those concerned about sexual dysfunction. While satisfaction rates with risk-reducing salpingo-oophorectomy (RRSO) remained high, regret rates were higher for premenopausal women compared to postmenopausal women. The use of hormone replacement therapy (HRT) following premenopausal RRSO did not increase satisfaction levels but did reduce symptoms of vaginal dryness.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Oncology

Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial

Faiza Gaba, Sadiyah Robbani, Naveena Singh, W. Glenn McCluggage, Nafisa Wilkinson, Raji Ganesan, Gareth Bryson, Gareth Rowlands, Charlotte Tyson, Rupali Arora, Ertan Saridogan, Helen Hanson, Matthew Burnell, Rosa Legood, D. Gareth Evans, Usha Menon, Ranjit Manchanda

Summary: Risk-reducing early salpingectomy is proposed as a two-step surgical alternative for pre-menopausal women declining or delaying oophorectomy, with the primary objective being to evaluate its impact on sexual function.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Article Economics

Cost-Utility Analysis of a Complex Intervention to Reduce School-Based Bullying and Aggression: An Analysis of the Inclusive RCT

Rosa Legood, Charles Opondo, Emily Warren, Farah Jamal, Chris Bonell, Russell Viner, Zia Sadique

Summary: The study demonstrates that a school-based intervention addressing bullying and aggression among children and young people is highly cost-effective, suggesting it should be considered for scaling up by education and health-sector policy makers.

VALUE IN HEALTH (2021)

Article Genetics & Heredity

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study

Faiza Gaba, Shivam Goyal, Dalya Marks, Dhivya Chandrasekaran, Olivia Evans, Sadiyah Robbani, Charlotte Tyson, Rosa Legood, Ertan Saridogan, W. Glenn McCluggage, Helen Hanson, Naveena Singh, D. Gareth Evans, Usha Menon, Ranjit Manchanda

Summary: The study identified seven interconnected themes integral to surgical decision making among BRCA carriers considering prophylactic surgeries, and highlighted that RRESDO offers premenopausal women a degree of ovarian cancer risk reduction while avoiding early menopause, particularly for those concerned about the impacts of menopause. Centralised care for high-risk women at specialist familial gynaecological cancer risk management centers is recommended to provide better-quality, streamlined, holistic multidisciplinary care.

JOURNAL OF MEDICAL GENETICS (2022)

Article Multidisciplinary Sciences

Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study

Angela Devine, Alice Vahanian, Bernard Sawadogo, Souleymane Zan, Fadima Yaya Bocoum, Helen Kelly, Clare Gilham, Nicolas Nagot, Jason J. Ong, Rosa Legood, Nicolas Meda, Alec Miners, Philippe Mayaud

Summary: The study in Burkina Faso estimated the costs and incremental cost per case detected of screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+) in women living with HIV (WLHIV). The average cost per screening test ranged from US$3.2 for VIA to US$24.8 for cytology. Despite higher costs, careHPV was more sensitive for CIN2+ cases detected compared to VIA/VILI.

PLOS ONE (2021)

Article Oncology

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

Dhivya Chandrasekaran, Monika Sobocan, Oleg Blyuss, Rowan E. Miller, Olivia Evans, Shanthini M. Crusz, Tina Mills-Baldock, Li Sun, Rory F. L. Hammond, Faiza Gaba, Lucy A. Jenkins, Munaza Ahmed, Ajith Kumar, Arjun Jeyarajah, Alexandra C. Lawrence, Elly Brockbank, Saurabh Phadnis, Mary Quigley, Fatima El Khouly, Rekha Wuntakal, Asma Faruqi, Giorgia Trevisan, Laura Casey, George J. Burghel, Helene Schlecht, Michael Bulman, Philip Smith, Naomi L. Bowers, Rosa Legood, Michelle Lockley, Andrew Wallace, Naveena Singh, D. Gareth Evans, Ranjit Manchanda

Summary: Multigene testing in ovarian cancer, especially after counselling by multidisciplinary clinical teams, shows a high uptake rate of 97% and identifies a significant proportion of patients with pathogenic variants such as BRCA1/BRCA2, RAD51C/RAD51D/BRIP1. Prospective parallel somatic and germline panel testing is recommended to maximize variant identification in cancer patients.

CANCERS (2021)

Article Obstetrics & Gynecology

Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study

D. Reisel, M. Burnell, L. Side, K. Loggenberg, S. Gessler, R. Desai, S. Sanderson, A. F. Brady, H. Dorkins, Y. Wallis, C. Jacobs, R. Legood, U. Beller, I Tomlinson, J. Wardle, U. Menon, I Jacobs, R. Manchanda

Summary: Jewish religious and cultural identity, as well as denominational affiliation, do not seem to significantly influence interest, intention, or uptake of population-based BRCA testing. BRCA testing shows robust uptake across all Jewish denominations.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Oncology

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China

Li Sun, Bin Cui, Xia Wei, Zia Sadique, Li Yang, Ranjit Manchanda, Rosa Legood

Summary: Unselected multigene testing for all Chinese women with breast cancer is highly cost-effective, preventing more cases of breast and ovarian cancer and reducing mortality rates.

CANCERS (2022)

Article Medicine, General & Internal

Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews

Faiza Gaba, Samuel Oxley, Xinting Liu, Xin Yang, Dhivya Chandrasekaran, Jatinderpal Kalsi, Antonis Antoniou, Lucy Side, Saskia Sanderson, Jo Waller, Munaza Ahmed, Andrew Wallace, Yvonne Wallis, Usha Menon, Ian Jacobs, Rosa Legood, Dalya Marks, Ranjit Manchanda

Summary: This qualitative study explores the attitudes, experiences, and emotional well-being impact of unselected population-based personalised ovarian cancer risk prediction through genetic testing in the general population. The results show high satisfaction and reduced anxiety in low-risk individuals. Facilitators include ease of testing, learning about children's risk, and a desire to prevent disease. Barriers include changes in family dynamics, insurance, stigmatization, and personality traits associated with stress and worry.

DIAGNOSTICS (2022)

Article Obstetrics & Gynecology

Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes

Matthew Burnell, Faiza Gaba, Monika Sobocan, Rakshit Desai, Saskia Sanderson, Kelly Loggenberg, Sue Gessler, Lucy Side, Angela F. Brady, Huw Dorkins, Yvonne Wallis, Chris Jacobs, Rosa Legood, Uziel Beller, Ian Tomlinson, Jane Wardle, Usha Menon, Ian Jacobs, Ranjit Manchanda

Summary: Population-based and family history-based AJ BRCA testing have similar long-term impacts on lifestyle and cancer risk perception, including smoking, alcohol consumption, diet, exercise, and breast screening behavior.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Health Care Sciences & Services

Telemammography for breast cancer screening: a cost-effective approach in Argentina

Victoria Alba Malek Pascha, Li Sun, Ramiro Gilardino, Rosa Legood

Summary: The study found that implementing annual tele-mammography screening for at-risk Argentine women over 40 years old can reduce breast cancer mortality and has a lower cost-effectiveness ratio. The model demonstrated that the program is cost-effective in 59% of simulations.

BMJ HEALTH & CARE INFORMATICS (2021)

Meeting Abstract Oncology

UPTAKE OF POPULATION BASED BRCA-TESTING ACROSS JEWISH DENOMINATIONS AND AFFECT OF CULTURAL AND RELIGIOUS FACTORS: A COHORT STUDY

D. Reisel, M. Burnell, L. Side, K. Loggenberg, S. Gessler, R. Desai, S. Sanderson, A. Brady, H. Dorkins, Y. Wallis, C. Jacobs, R. Legood, U. Beller, I. Tomlinson, U. Menon, I. Jacobs, R. Manchanda

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Meeting Abstract Oncology

ATTITUDES TOWARDS RISK REDUCING EARLY SALPINGECTOMY WITH DELAYED OOPHORECTOMY FOR OVARIAN CANCER PREVENTION: A COHORT STUDY

Faiza Gaba, Oleg Blyuss, Rosa Legood, Louise Izatt, Vishakha Tripathi, Kalpana Ragupathy, Robin Crawfordd, D. Gareth Evans, Usha Menon, Ranjit Manchanda

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Meeting Abstract Oncology

SURGICAL DECISION MAKING IN PREMENOPAUSAL BRCA CARRIERS CONSIDERING RISK REDUCING EARLY-SALPINGECTOMY OR SALPINGO-OOPHORECTOMY: A QUALITATIVE STUDY

Faiza Gaba, Dalya Marks, Ertan Saridogan, W. Glenn Mccluggage, Helen Hanson, Naveena Singh, Rosa Legood, D. Gareth Evans, Usha Menon, Ranjit Manchanda

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

No Data Available